Biotech China 2014

View Profile


Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2009 PET/CT and Biologically Conformal Radiation Therapy book chapter in Image Guided and Adaptive Radiation Therapy; expected publication 2009 (Lippincott Williams & Wilkins).
2. 2008 Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small cell lung cancer: An analysis of RTOG 9801 Int J Radiat Oncol Biol Phys 2008 (in press; Epub May 21, 2008).
3. 2008 Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis. J Clin Oncol 2008 (in press; Epub Jun 16, 2008).
4. 2008 Treatment of Lung Cancer: Radiation Therapy Pulmonary Diseases and Disorders 4th Edition
5. 2008 “Pulmonary complications of anti-cancer treatment,” 10.              updated chapter in Clinical Oncology 4th edition; (M Abeloff MD editor in chief); expected publication 2008.
6. 2008 Celebrating 40 years of clinical inquiry: The RTOG’s ruby anniversary Int J Radiat Oncol Biol Phys 2008 Jun 1; 71(2):321-3
7. 2008 Gustatory impairment in patients undergoing head and neck irradiation. Laryngoscope. 2008 Jan; 118(1):24-31
8. 2008 New advances in high-technology radiotherapy for head and neck cancer Heme Onc Clinics NA, 2008
9. 2008 Radiation treatment breaks and ulcerative mucositis in head and neck cancer. Oncologist, 2008
10. 2008 The final report of RTOG 9610: A Multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck Head and Neck, 2008 Mar; 30(3):281-8.
11. 2007 Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: A randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03). Int J Radiat Oncol Biol Phys. 2007 Nov 15; 69(4):1008-17
12. 2007 A phase II trial of subcutaneous amifostine and radiation therapy in patients with head and neck cancer Int J Radiat Oncol Biol Phys. 2007 Feb 1; 67(2):445-52.
13. 2007 The risk of death from heart disease in patients with non-small cell lung cancer who receive postoperative radiotherapy – Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database Cancer, 2007 Aug 15; 110(4):911-7.
14. 2007 Neck dissection followed by chemoradiotherapy for stage IV (N+) oropharynx cancer Otolaryngology-Head and Neck Surgery, 2007 Sep; 137(3):416-21
15. 2006 Systemic polyethylene glycol-modified (PEGylated) superoxide dismutase and catalase mixture attenuates radiation pulmonary fibrosis in the C57BL/6 mouse. Radiother Oncol 2006 Nov; 81(2):196-205
16. 2006 Adverse event reporting and developments in radiation biology after normal tissue injury: International Atomic Energy Agency consultation Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1442-51
17. 2006 Altered fractionation: a fractional benefit? Lancet 2006; 368:819-20.
18. 2006 Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone? J Clin Oncol. 2006 Jun 10;24(17):2653-8.
19. 2006 Preliminary investigation of symptom distress in the head and neck patient population: validation of a measurement instrument   Am J Clin Oncol. 2006 Apr;29(2):158-62.
20. 2006 Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced non-small cell lung cancer. J Thorac Oncol, 2006 Jan; 1(1):38-45
21. 2005 Pilot study of accelerated radiotherapy with concurrent chemotherapy for stage III non-small cell lung cancer. Semin Oncol. 2005 Apr; 32 (2 Suppl 3): S9-12.
22. 2005 Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience Int J Radiat Oncol Biol Phys. 2005, Nov 1;63(3):667-71
23. 2005 Study of Paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: A Radiation Therapy Oncology Group 9609 Phase II study. J Clin Oncol. 2005, Aug 1; 23(22):4991-8.
24. 2005 Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinoma of the oropharynx and hypopharynx. Am J Clin Oncol. 2005 Aug; 28(4) 385-392.
25. 2005 Randomized trial of amifostine in locally advanced non-small cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: Radiation Therapy Oncology Group trial 98-01. J Clin Oncol. 2005, Apr 1; 23(10): 2145-54.
26. 2005 Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group – RTOG 97-05 J Clin Oncol. 2005, May 20; 23(15):3480-7.
27. 2004 Pulmonary complications of anti-cancer treatment chapter 62 in Clinical Oncology 3rd edition; (Abeloff MD editor in chief)
28. 2004 Concurrent radiochemotherapy in the treatment of locally advanced non-small cell lung cancer Hematol Oncol Clin North Am. 2004 Feb;18(1):91-100
29. 2004 New tactics for exploratory clinical trails of concurrent chemoradiation J Clin Oncol 2004 Jan 15;22(2):214-6.
30. 2004 Signaling pathways in NSCLC as a predictor of outcome and response to therapy. Lung. 2004: 182(3): 151-162
31. 2004 Intraobserver variability in the MR determination of tumor volume in squamous cell carcinoma of the pharynx AJNR Am J Neuroradiol. 2004 Jun-Jul;25(6):1092-8.
32. 2004 Radiation Therapy Oncology Group 9501/Intergroup Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck N Engl J Med. 2004 May 6;350(19):1937-44.
33. 2004 A pilot study of postoperative reirradiation/chemotherapy/amifostine after surgical salvage for recurrent head and neck cancer Int J Radiat Oncol Biol Phys 2004 May 1;59(1):72-7
34. 2004 Final report of a pilot trial of accelerated radiotherapy plus concurrent 96-hour infusional paclitaxel for locally advanced head and neck cancer. Am J Clin Oncol. 2004 Dec; 27 (6): 595-602
35. 2004 Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response. J Thor CV Surg 2004. Jan; 127(1):108-13.
36. 2003 Complex and controversial issues in locally advanced non-small cell lung cancer. Seminars in Surgical Oncology, 21:128-137
37. 2003 Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol 2003; 21:1904-1911.
38. 2002 Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: a University of Pennsylvania phase II trial. J Clin Oncol 2002; 20:3964-3971
39. 2002 Relative risk of stroke in head and neck carcinoma patients treated with external cervical irradiation Laryngoscope 2002; 112:1883-7
40. 2002 Changes in plasma gelsolin concentration during acute oxidant lung injury in mice. Lung 2002; 180:91-104
41. 2002 A Phase I study of SPI-077 (Stealth Liposomal Cisplatin) concurrent with radiation therapy for locally advanced head and neck cancer Investigational New Drugs, 2002; 20:343-349
42. 2002 Pathologic response to preoperative chemoradiation worsens with anemia in non-small cell lung cancer patients The Cancer Journal, 2002; 8:263-267
43. 2002 Local recurrence in head and neck cancer: relationshipo to radiation resistance and signal transduction. Clinical Cancer Research 2002; 8(3):885-892
44. 2002 The importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck Head and Neck 2002; 24:115-126.
45. 2002 Nasopharyngeal carcinoma treated with external radiotherapy, brachytherapy, and concurrent/adjuvant chemotherapy Am J Clin Oncol 2002; 25(1):93-95.
46. 2002 A phase III comparison of radiation therapy with or without recombinant beta-interferon for patients with locally advanced non-small cell lung cancer Int J Radiat Oncol Biol Phys 2002; 52:1173-1179.
47. 2002 The Early Rad Catches the Tumor? (Editorial on sequencing of chemotherapy and radiation for limited stage small cell lung carcinoma). J Clin Oncol 2002 20:3045-3047
48. 2002 Combined modality therapy for non-small cell lung carcinoma The Cancer Journal, 2002; 8(Suppl 1):S55-S67
49. 2002 Postoperative adjuvant therapy for non-small cell lung carcinoma Oncology 2002; 16(1):100-101
50. 2002 The effect of a short course of neoadjuvant hormone treatment on the response to subsequent androgen suppression in prostate cancer patients who relapse following radiation therapy: A secondary analysis of the randomized protocol RTOG 86-10. Int J Radiat Oncol Biol Phys 2002; 54:1302-1310.
51. 2001 RTOG 9610: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck Int J Radiat Oncol Biol Phys 2001; 51:1299-1304.
52. 2001 The risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high risk resected non-small cell lung carcinoma J Clin Oncol 2001; 19:3912-3917
53. 2001 Advanced resectable oropharyngeal carcinoma treated with surgery and postoperative radiotherapy: oncologic outcome and functional assessment Am J Otolaryngol. 2001; 22:329-335.
54. 2001 Tumor Hypoxia/anemia is a negative prognostic factor for the outcome of radiotherapy – Is it sufficient to correct hemoglobin levels during radiotherapy or should it preferentially be done before radiotherapy? Editorial in Focus on Anaemia in Cancer, 2001 Issue 2.
55. 2001 The Relationship between Anemia and Tumor Control Probability after Radiotherapy. Oncology 2001; 15 (11):1495-1496
56. 2001 Updated results of the phase III radiation therapy oncology group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression deprivation following standard radiation therapy for unfavorable prognosis carcinoma of the prostate Int J Radiat Oncol Biol Phys 2001; 49:937-946.
57. 2001 Subset analysis of RTOG 85-31 and 86-10 indicates an advantage for long-term versus short-term adjuvant hormones for patients with locally advanced non-metastatic prostate cancer treated with radiation therapy Int J Radiat Oncol Biol Phys 2001; 49:947-956
58. 2001 Radiotherapy with 6MV Photons for Early Glottic Carcinoma: Potential Impact of Extension the the Posterior One-Third of the Vocal Cord Am J Otolaryngology 2001; 22:43-54.
59. 2001 Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small cell lung carcinoma. J Clin Oncol 2001; 19:1344-1349.
60. 2001 Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma of the head and neck.. J Clin Oncol 2001; 19:1363-1373
61. 2001 Evaluation of recurrent squamous cell carcinoma of the head and neck with FDG positron emission tomography Clin Nuc Med 2001; 26:131-135
62. 2001 Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate Int J Radiat Oncol Biol Phys 2001; 50:1243-1252.
63. 2000 The role of radiation therapy in the management of non-small cell lung cancer. Semin Thoracic & Cardiovascular Surg 1997; 9(1):80-89.
64. 2000 Radiation Therapy for Head and Neck Cancer; (Book Chapter in Oral and Maxillofacial Surgery), 4.                  W.B. Saunders, Philadelphia. Volume 5, Section I, Chapter 2.
65. 2000 Special Considerations for Radiation Therapy Following Laryngeal Conservation Surgery Weinstein GS, ed., 2000. Singular Pub Group, San Diego
66. 2000 Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer Int J Radiat Oncol Biol Phys 2000; 48:89-94.
67. 2000 A Pilot Study of Organ prservation multimodality therapy for locally advanced resectable oropharyngeal carcinoma Am J Clin Oncol 2000; 23:509-515.
68. 2000 Morbidity following midline mandibulotomy and radiation therapy. Am J Otolaryngology 2000; 21:312-317.
69. 1999 Seven-week Continuous Infusion Paclitaxel Concurrent with Radiation Therapy for Locally Advanced Non-small Cell Lung and Head and Neck Cancer Semin Radiation Oncol 1999; 9 (Suppl 1): 97-101.
70. 1999 Are Patients with Supraclavicular Node Metastases in Non-small Cell Lung Cancer (NSCLC) Curable with Chemoradiotherapy? Int J Radiat Oncol Biol Phys. 1999; 44:847-853
71. 1999 A Phase I Trial of 96-hour Taxol Infusion plus Accelerated Radiotherapy for Unresectable Head and Neck Cancer Int. J. Radiation Oncology Biol Phys. 1999; 44:311-315.
72. 1999 Detection of Recurrent Head and Neck Squamous Cell Carcinomas after Radiation Therapy with 2-18F-Fluoro-2-deoxy-D-glucose Positron Emission Tomography Laryngoscope 1999; 109:970-975
73. 1999 The significance of pretreatment hemoglobin level in patients with T1 glottic cancer Radiation Oncology Investigations 1999; 7:42-48
74. 1999 Is Meta-analysis really Meta-physics? (editorial discussing the limitations of meta-analyses in oncology, with emphasis on the recent PORT Chest 1999; 116:539-542.
75. 1999 Prognostic Factors in Patients with Non-small cell Lung Cancer Treated with Surgery and Postoperative Radiation Therapy Radiology 1999; 213:845-852
76. 1999 Dual time point fluorine-18 deoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck Eur J Nuc Med, 1999; 26:1345-1348.
77. 1999 Lung and aero-digestive cancers in young marijuana smokers. Tumori 1999; 85(2):140-142
78. 1998 Just Another Statistic Editorial, Commentary on surrogate endpoints such as disease-free-survival, in The Oncologist, 1998; 3:0-iii
79. 1998 Second Malignant Neoplasia in Patients with T1 Glottic Cancer Treated with Radiation Laryngoscope 1998; 108:1853-1855.
80. 1998 Postoperative radiotherapy in non-small cell lung carcinoma Lancet 1998; 352:1384-5.
81. 1998 Prophylactic Gastrostomy Tubes in Patients Undergoing Intensive Irradiation for Cancer of the Head and Neck. Archives of Otolaryngology-Head&Neck Surgery 1998; 124:871-875.
82. 1997 Combined surgery and postoperative radiotherapy for carcinoma of the base of tongue. Head and Neck 1997; 19:494-499
83. 1997 The role of radiation therapy in the management of non-small cell lung cancer. Semin Thoracic & Cardiovascular Surg 1997; 9(1):80-89
84. 1997 Introduction to Radiation Oncology for the Medical Student a multimedia presentation on the University of Pennsylvania School of Medicine Intranet 1997 (Joel Goldwein editor.) (www.xrt.upenn.edu).
85. 1997 The use of combined radiation therapy and hormonal therapy in the management of lymph node positive prostate cancer Int J Radiation Oncology Biol Phys 1997; 39:673-680.
86. 1996 Treatment of Lung Cancer: Radiation Therapy chapter in Pulmonary Diseases and Disorders 3rd Edition; AP Fishman editor in chief, McGraw-Hill, 1996
87. 1995 Decreased acute toxicity by midline mucosa-sparing blocks during radiotherapy for carcinoma of the oropharynx, oral cavity and nasopharynx Radiology 1995; 197:863-866
88. 1994 Inaccuracies in using the lumpectomy scar for planning electron boosts in primary breast carcinoma Int. J. Radiation Oncology Biol Phys 1994; 30:43-48.


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.